Glanzmann's thrombasthenia other diagnostic studies: Difference between revisions
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Glanzmann's thrombasthenia}} | {{Glanzmann's thrombasthenia}} | ||
{{CMG}} {{AE}} {{OK}} | {{CMG}} {{AE}} {{OK}} | ||
==Overview== | ==Overview== | ||
A bedside automated whole [[blood]] assay that measures [[platelet aggregation]]. It works on the principle of activated [[platelets]] binding to [[fibrinogen]] | |||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
=== Ultegra === | |||
A bedside automated whole [[blood]] assay that measures [[platelet aggregation]]. It works on the principle of activated [[platelets]] binding to [[fibrinogen]] | |||
==References== | ==References== |
Revision as of 17:35, 11 December 2018
Glanzmann's thrombasthenia |
Differentiating Glanzmann's thrombasthenia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glanzmann's thrombasthenia other diagnostic studies On the Web |
American Roentgen Ray Society Images of Glanzmann's thrombasthenia other diagnostic studies |
Glanzmann's thrombasthenia other diagnostic studies in the news |
Blogs on Glanzmann's thrombasthenia other diagnostic studies |
Risk calculators and risk factors for Glanzmann's thrombasthenia other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
A bedside automated whole blood assay that measures platelet aggregation. It works on the principle of activated platelets binding to fibrinogen
Other Diagnostic Studies
Ultegra
A bedside automated whole blood assay that measures platelet aggregation. It works on the principle of activated platelets binding to fibrinogen